Skip to content
← Index board

Health Optimization Index

Kava (Piper methysticum)

Nick’s assessment
Experimental
Research evidence
B, good evidence
Attention
25.0 / 100▲ Rising this week
5.5/ 10

BioHarmony score

Kava (Piper methysticum) is a Pacific anxiolytic root whose kavalactones cut Hamilton Anxiety scores by a weighted mean of 3.9 points across 7 trials per the Pittler 2003 Cochrane review. A real but rare liver-injury signal holds the BioHarmony score at 5.5–6.0/10.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

Kava is a real, fast-acting, non-addictive anxiolytic with a strong short-term and traditional evidence base, limited by one specific intrinsic safety problem rather than by weak efficacy. It is worth considering for adults with situational or short-term generalized anxiety who want benzodiazepine-like relief without the addiction risk, and who will respect the sourcing rules. It should be avoided by anyone with liver concerns or alcohol use. The effective-but-risky balance is the whole story here, and it is not that the plant does not work.

✅ Best for: Adults with situational anxiety (public speaking, flights, stressful events) who want fast relief without a daily prescription. People with short-term generalized anxiety seeking a non-addictive alternative to benzodiazepines who will keep courses short. Those who specifically want to avoid the dependence, withdrawal, and sexual side effects of conventional anxiolytics, a profile Sarris 2009 supports. Careful consumers who will buy verified noble-cultivar aqueous root products and monitor how they respond. People who tried other calming supplements with no effect and want something with a genuine clinical signal.

❌ Avoid if: You have any liver disease or elevated liver enzymes, since the intrinsic hepatotoxicity risk is the whole story here. You drink alcohol regularly or take acetaminophen, because the combination compounds liver stress. You are pregnant or breastfeeding. You take medications metabolized by cytochrome P450 enzymes, which kava inhibits, raising interaction risk. You are looking for a long-term anxiety solution, given the null 16-week Sarris 2020 result. Sourcing caveat: never buy unlabeled concentrates, acetone or ethanol extracts, aerial-part products, or non-noble tudei kava, which is where most liver-injury reports originate.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on Kava (Piper methysticum)
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 21, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.